Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial.
Tokunaga M, Kurokawa Y, Machida R, Sato Y, Takiguchi S, Doki Y, Yabusaki H, Watanabe M, Hato S, Nakamori M, Ito S, Yoshikawa T, Terashima M. Tokunaga M, et al. Among authors: watanabe m. Gastric Cancer. 2021 Jan;24(1):214-223. doi: 10.1007/s10120-020-01102-3. Epub 2020 Jun 29. Gastric Cancer. 2021. PMID: 32601909
Preoperative skeletal muscle index and visceral-to-subcutaneous fat area ratio are associated with long-term outcomes of elderly gastric cancer patients after gastrectomy.
Taki Y, Sato S, Nakatani E, Higashizono K, Nagai E, Nishida M, Watanabe M, Ohata K, Kanemoto H, Oba N. Taki Y, et al. Among authors: watanabe m. Langenbecks Arch Surg. 2021 Mar;406(2):463-471. doi: 10.1007/s00423-021-02092-1. Epub 2021 Jan 30. Langenbecks Arch Surg. 2021. PMID: 33515316
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.
Mitani S, Kato K, Daiko H, Ito Y, Nozaki I, Kojima T, Yano M, Nakagawa S, Ueno M, Watanabe M, Tsunoda S, Abe T, Kadowaki S, Kadota T, Sasaki K, Machida R, Kitagawa Y. Mitani S, et al. Among authors: watanabe m. J Gastroenterol. 2022 Jul;57(7):455-463. doi: 10.1007/s00535-022-01870-y. Epub 2022 May 11. J Gastroenterol. 2022. PMID: 35546373 Free PMC article.
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
Yamaguchi T, Takashima A, Nagashima K, Kumagai K, Yamada T, Terashima M, Yabusaki H, Nishikawa K, Tanabe K, Yunome G, Kawachi Y, Yamada T, Fukagawa T, Kinoshita T, Watanabe M, Ishiyama K, Inoue K, Boku N. Yamaguchi T, et al. Among authors: watanabe m. Gastric Cancer. 2023 Mar;26(2):307-316. doi: 10.1007/s10120-023-01363-8. Epub 2023 Jan 25. Gastric Cancer. 2023. PMID: 36695982
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol.
Makuuchi R, Terashima M, Terada M, Mizusawa J, Kita R, Tokunaga M, Omori T, Ojima T, Ehara K, Watanabe M, Yanagimoto Y, Nunobe S, Kinoshita T, Ito S, Nishida Y, Hihara J, Boku N, Kurokawa Y, Yoshikawa T; Stomach Cancer Study Group of Japan Clinical Oncology Group. Makuuchi R, et al. Among authors: watanabe m. BMC Cancer. 2023 Oct 17;23(1):987. doi: 10.1186/s12885-023-11481-2. BMC Cancer. 2023. PMID: 37845660 Free PMC article.
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study).
Tokunaga M, Machida N, Mizusawa J, Ito S, Yabusaki H, Hirao M, Watanabe M, Imamura H, Kinoshita T, Yasuda T, Hihara J, Fukuda H, Yoshikawa T, Boku N, Terashima M. Tokunaga M, et al. Among authors: watanabe m. Gastric Cancer. 2024 May;27(3):580-589. doi: 10.1007/s10120-024-01467-9. Epub 2024 Jan 19. Gastric Cancer. 2024. PMID: 38243037 Clinical Trial.
27 results